Overview
Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer.
Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.
Eligibility
Inclusion Criteria: patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical
resection or other benign lung lesions need VATS surgery.
-
Exclusion Criteria: cardio-pulmonary function couldn't tolerate surgery
-